Divalproex sodium 125 MG Delayed Release Oral Capsule — RxCUI 1099596
RxNorm drug concept · Semantic clinical drug
RxCUI 1099596
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
42 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1099596
Official nameDivalproex sodium 125 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped18
Package NDCs mapped42
Reported Medicaid activity (SDUD)218,244 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Divalproex: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats seizures, manic episodes of bipolar disorder, and prevents migraines. Which uses apply depends on the product. Capsules are only for seizures. Ask me to check which one y...
- Swallow tablets whole and never crush or chew them. Extended-release tablets are once a day. Capsules can be swallowed whole or sprinkled on soft food and swallowed right away. Tak...
- For delayed-release tablets, take it as soon as you remember unless it is almost time for the next dose. Do not double up. Ask your prescriber if you take another form.
- Nausea, stomach upset, sleepiness, dizziness, tremor, headache and hair loss are common. Call your doctor if they bother you a lot. Call right away for severe stomach pain, vomitin...
🕸️ Concept Web — How Divalproex sodium 125 MG Delayed Release Oral Ca... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Divalproex sodium 125 MG Delayed Release Oral Capsule
RxCUI 1099596 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Valproate
40254IN -
Divalproex sodium
266856PIN
-
Valproate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Depakote
216459BN
-
Depakote
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Valproate Delayed Release Oral Capsule
808586SCDF -
Divalproex sodium Delayed Release Oral Capsule
2649486SCDFP -
Valproate Oral Product
1159996SCDG -
Valproate Pill
1159997SCDG -
Divalproex sodium Oral Product
2663486SCDGP -
Divalproex sodium Pill
2659303SCDGP -
Valproate Delayed Release Oral Capsule [Depakote]
808588SBDF -
Divalproex sodium Delayed Release Oral Capsule [Depakote]
2655752SBDFP - +5 more in this family
-
Valproate Delayed Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Divalproex sodium 125 MG
1099595SCDC -
Divalproex sodium 125 MG Delayed Release Oral Capsule [Depakote]
1099598SBD -
Divalproex sodium 125 MG [Depakote]
1099597SBDC
-
Divalproex sodium 125 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Divalproex sodium 125 MG
SCDC · 1099595 -
Valproate Delayed Release Oral Capsule
SCDF · 808586 -
Divalproex sodium Delayed Release Oral Capsule
SCDFP · 2649486 -
Valproate Oral Product
SCDG · 1159996 -
Valproate Pill
SCDG · 1159997 -
Divalproex sodium Oral Product
SCDGP · 2663486 -
Divalproex sodium Pill
SCDGP · 2659303
Brand-Name Concepts
-
Divalproex sodium 125 MG Delayed Release Oral Capsule [Depakote]
SBD · 1099598 -
Divalproex sodium 125 MG [Depakote]
SBDC · 1099597 -
Valproate Delayed Release Oral Capsule [Depakote]
SBDF · 808588 -
Divalproex sodium Delayed Release Oral Capsule [Depakote]
SBDFP · 2655752 -
Depakote Oral Product
SBDG · 1173098 -
Depakote Pill
SBDG · 1173099 -
Depakote
BN · 216459
📦 FDA Products & Package NDCs
18 products · 42 package NDCs
42 package NDCs map to RxCUI 1099596 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-6114-13 | 100 CAPSULE in 1 BOTTLE (0074-6114-13) | Depakote Sprinkles | AbbVie Inc. | 1989-09-12 |
| 00615-8237-05 | 15 CAPSULE in 1 BLISTER PACK (0615-8237-05) | Divalproex sodium | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-08-27 |
| 00615-8237-28 | 28 CAPSULE in 1 BLISTER PACK (0615-8237-28) | Divalproex sodium | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-04-19 |
| 00615-8237-30 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8237-30) / 5 CAPSU... | Divalproex sodium | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-08-27 |
| 00615-8237-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8237-39) | Divalproex sodium | NCS HealthCare of KY, LLC dba Vangard Labs | 2018-08-27 |
| 00904-6615-61 | 100 BLISTER PACK in 1 CARTON (0904-6615-61) / 1 CAPSULE, DE... | Divalproex sodium | Major Pharmaceuticals | 2009-01-23 |
| 17856-0109-01 | 100 POUCH in 1 BOX (17856-0109-1) / 1 CAPSULE, COATED PELLE... | divalproex sodium | ATLANTIC BIOLOGICALS CORP. | 2021-01-28 |
| 27241-0115-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-01) | Divalproex sodium | Ajanta Pharma USA Inc. | 2020-05-15 |
| 27241-0115-05 | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-05) | Divalproex sodium | Ajanta Pharma USA Inc. | 2020-05-15 |
| 27241-0115-10 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-10) | Divalproex sodium | Ajanta Pharma USA Inc. | 2020-05-15 |
| 46708-0821-10 | 100 BLISTER PACK in 1 CARTON (46708-821-10) / 10 CAPSULE, D... | Divalproex sodium | Alembic Pharmaceuticals Limited | 2024-12-23 |
| 46708-0821-31 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-821-31) | Divalproex sodium | Alembic Pharmaceuticals Limited | 2024-12-23 |
| 46708-0821-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-821-91) | Divalproex sodium | Alembic Pharmaceuticals Limited | 2024-12-23 |
| 55111-0532-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-01) | Divalproex sodium | Dr. Reddy's Laboratories Ltd | 2009-01-23 |
| 55111-0532-05 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-05) | Divalproex sodium | Dr. Reddy's Laboratories Ltd | 2009-01-23 |
| 55111-0532-30 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-532-30) | Divalproex sodium | Dr. Reddy's Laboratories Ltd | 2009-01-23 |
| 55111-0532-78 | 10 BLISTER PACK in 1 CARTON (55111-532-78) / 10 CAPSULE, DE... | Divalproex sodium | Dr. Reddy's Laboratories Ltd | 2009-01-23 |
| 55154-3552-00 | 10 BLISTER PACK in 1 BAG (55154-3552-0) / 1 CAPSULE, DELAYE... | Divalproex sodium | Cardinal Health 107, LLC | 2009-01-23 |
| 55154-4759-00 | 10 BLISTER PACK in 1 BAG (55154-4759-0) / 1 CAPSULE, COATED... | Divalproex Sodium | Cardinal Health 107, LLC | 2009-03-18 |
| 62332-0821-10 | 100 BLISTER PACK in 1 CARTON (62332-821-10) / 10 CAPSULE, D... | Divalproex sodium | Alembic Pharmaceuticals Inc. | 2024-12-23 |
| 62332-0821-31 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-31) | Divalproex sodium | Alembic Pharmaceuticals Inc. | 2024-12-23 |
| 62332-0821-71 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-71) | Divalproex sodium | Alembic Pharmaceuticals Inc. | 2025-03-21 |
| 62332-0821-91 | 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-821-91) | Divalproex sodium | Alembic Pharmaceuticals Inc. | 2024-12-23 |
| 65841-0639-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-639-01) | divalproex sodium | Zydus Lifesciences Limited | 2009-01-27 |
| 65841-0639-10 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-639-10) | divalproex sodium | Zydus Lifesciences Limited | 2009-01-27 |
| 65841-0639-30 | 10 BLISTER PACK in 1 CARTON (65841-639-30) / 10 CAPSULE, CO... | divalproex sodium | Zydus Lifesciences Limited | 2009-01-27 |
| 68084-0313-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-313-01) / 1 CAP... | Divalproex Sodium | American Health Packaging | 2009-03-18 |
| 68084-0313-65 | 50 BLISTER PACK in 1 CARTON (68084-313-65) / 1 CAPSULE, COA... | Divalproex Sodium | American Health Packaging | 2024-06-26 |
| 68382-0106-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-01) | divalproex sodium | Zydus Pharmaceuticals USA Inc. | 2009-01-27 |
| 68382-0106-10 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-10) | divalproex sodium | Zydus Pharmaceuticals USA Inc. | 2009-01-27 |
| 68382-0106-77 | 100 BLISTER PACK in 1 CARTON (68382-106-77) / 1 CAPSULE, CO... | divalproex sodium | Zydus Pharmaceuticals USA Inc. | 2009-01-27 |
| 70518-1749-01 | 100 POUCH in 1 BOX (70518-1749-1) / 1 CAPSULE, COATED PELLE... | divalproex sodium | REMEDYREPACK INC. | 2018-12-17 |
| 70518-3457-02 | 100 POUCH in 1 BOX (70518-3457-2) / 1 CAPSULE, COATED PELLE... | Divalproex sodium | REMEDYREPACK INC. | 2023-08-01 |
| 70518-3457-04 | 30 CAPSULE, COATED PELLETS in 1 BLISTER PACK (70518-3457-4) | Divalproex sodium | REMEDYREPACK INC. | 2026-02-18 |
| 70756-0447-11 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (70756-447-11) | divalproex sodium | Lifestar Pharma LLC | 2025-08-12 |
| 70756-0447-12 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (70756-447-12) | divalproex sodium | Lifestar Pharma LLC | 2025-08-12 |
| 70756-0447-30 | 30 CAPSULE, COATED PELLETS in 1 BOTTLE (70756-447-30) | divalproex sodium | Lifestar Pharma LLC | 2025-08-12 |
| 70756-0447-51 | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (70756-447-51) | divalproex sodium | Lifestar Pharma LLC | 2025-08-12 |
| 72603-0260-01 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72603-260-01) | Divalproex sodium | NorthStar Rx LLC | 2024-08-01 |
| 72603-0260-02 | 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72603-260-02) | Divalproex sodium | NorthStar Rx LLC | 2024-08-01 |
| 81469-0492-01 | 100 CAPSULE, COATED PELLETS in 1 BOTTLE (81469-492-01) | divalproex sodium | First Nation Group, LLC | 2025-11-10 |
| 81469-0492-10 | 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (81469-492-10) | divalproex sodium | First Nation Group, LLC | 2025-11-10 |
Observed labelers:
Alembic Pharmaceuticals Inc. (4) ·
Dr. Reddy's Laboratories Ltd (4) ·
Lifestar Pharma LLC (4) ·
NCS HealthCare of KY, LLC dba Vangard Labs (4) ·
Ajanta Pharma USA Inc. (3) ·
Alembic Pharmaceuticals Limited (3)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.